1. Dibbern D.A Jr, Dreskin S.C. Urticaria and angioedema an overview.Immunol Allergy Clin N Am 2004; 24:141-162. 

2. Monroe E, Finn A, Patel P, Guerrero R, Ratner P. Efficacy and safety of Desloratadine 5 mg once daily in the treatment chronic idiopathic urticaria: A double-blind, randomized, placebo controlled trial. J A Acad Dermatol 2003; 48:535-41.

3. Di Lorenzo G, Pacor ML, Mansueto P, Pellitteri ME, Lo Bianco C, Ditta V, Martinelli N, Rini GB. Ramdomized placebo-controlled trial compared desloratadine and montelukast in monotherapy and montelukast plus desloratadine in combined therapy for chronic idiopathic urticaria. J Allergy Clin Immunol 2004; 104:619-25.

4. Negro Alvarez JM, Miralles Lopez JC. Chronic idiopathic urticaria treatment. Allergol et Immunopathol 2001; 29(4):129-32.

5. Greaves Malcolm. Chronic urticaria. J Allergy Clin Immunol 2000; 105:664-72.

6. Di Gioacchino M, Di Stefano F, Cavallucci E, Verna N, Ramondo S, Paolini F, Caruso R, Schiavone C, Masci S, Santucci B, Paganelli R, Conti P. Treatment of chronic idiopathic urticaria and positive autologous serum skin test with cyclosporine: Clinical and Immunologicalevaluation. Allergy and Asthma Proceedings 2003; 24(4):285-290.

7. Allen P. Kaplan. Chronic urticaria: pathogenesis and treatment. J Allergy Clin Immunol 2004; 114:465-74.

8. Zulal Erbagci. The leukotriene receptor antagonist montelukast in the treatment of chronic idiopathic urticaria: a single blind, placebo-controlled, crossover clinical study. J Allergy Clin Immunol 2002; 110:484-8.

9. Allen P. Kaplan. Chronic urticaria and Angioedema. N Engl J Med 2002; 346(3):175-179.

10. Simons Estelle R. H1 Antihistamines: more relevant than ever in the treatment of allergic disorders. J Allergy Clin Immunol 2003; 142:S42-52.

11. Anad M, Nelson H. A possible role for cyclooxigenasa 2 inhibitors in the treatment of chronic urticaria. J Allergy Clin Immunol 2003;111(5):1133

12. Monroe E.W, Cohen S.H, Kalbfleisch J, Schulz C.I. Combined H1 and H2 antihistamines therapy in chronic urticaria. Archives of Dermatology (abstract) 1981; 117:404-407.

13. Lawlor F, Kobza Black A. Delayed pressure urticaria. Immunol Allergy Clin N Am 2004; 24:247-258.

14. Cassano N, Argento V, Filotico R. Low-Dose Dapsone in chronic idiopatic urticaria: preliminar results of an open study. Acta Derm Venereol 2004; 85: 255

15. Sheikh J. Advances in the treatment of chronic urticaria. Immunol Allergy Clin N Am 2004; 24:317-334.

16. Greaves W.M. Chronic urticaria. N Engl J Med 1995; 332(26):1767-1772.

17. Kozel Martina M.A, Mekkes Jan R, Bossuyt P M.M, Bos Jan D. The effectiveness of history-based diagnostic approach in chronic urticaria and angioedema. Arch Dermatol 1998; 134:1575-1580.

18. Zuberbier T. Urticaria. Allergy 2003; 58: 1224-1234.

19. Join Task Force on Practice Parameters. The diagnosis and management of urticaria: a practice parameter part I: acute urticaria/angioedema. Part II: chronic urticaria/angioedema. Ann Allergy Asthma Immunol 2000;85; 521-544.

20. Grattan CE. The urticaria spectrum: recognition of clinical patterns can help management. Clinical and Experimental Dermatology 2004;29:217-221.

21. Sridharan Soundararajan, Yoko Kikuchi, Kusuman Joseph, Kaplan Allen P. Functional assessment of pathogenic IgG subclasses in chronic autoimmune urticaria. J Allergy Clin Immunol 2005; 815-21.

22. Kikuchi Yoyo, Kaplan Allen P. A role for C5b in augmentin IGg-dependenthistamine release from basophils in Chronic Urticaria. J Allergy Clin Immunol 2001; 114-18.

23. Wedi Bettina, Vera Novacovic, Michael Koerner, Kapp Alexander. Chronic urticaria serum induces histamine release, leukotriene production, and basophil CD63 surface expression-inhibitory effects of anti-inflammatory drugs.  J Allergy Clin Immunol 1999; 552-60.

24. Kikuchi Yoyo, DVM, MVPM, and Allen P. Kaplan, MD. Mechanisms of autoimmune activation of basophils in chronic urticaria. J Allergy Clin Immunol 2001; 1056-62.

25. Wisnieski JJ, Jones Sm. IgG autoantibodies to the collagen-like region of C1q in hypocomplementemic urticarial vasculitis syndrome and systemic lupus erythematosus. J Immunol 1992; 148: 1396-403.

26. Perelman O. Ronald. Urticarial venulitis. Dermatologic Therapy 2000; 400-08.

27. Asero R, Lorini M, Chong S.U., Zuberbier T, Tedeschi A. Assessment of histamine-releasing activity of sera from patients with chronic urticaria showing positive autologous skin test on human basophils and mast cells. Clin. Exp. Allergy; 34: 1111-1114.

28. Sabroe RA, Fiebiger E, Francis DM, Maurer D, Seed PT, Grattan CE, Black AK, Stingl G, Greaves MW, Barr RM. Classification of anti-FcepsilonRI and anti-IgE autoantibodies in chronic idiopathic urticaria and correlation with disease severity. J Allergy Clin Immunol. 2002 Sep;

    110(3):492-9.

29. Grattan CE, Sabroe RA, Greaves MW. Chronic urticaria. J Am Acad Dermatol.2002 May; 46(5):645-57.

30. Soter Nicholas A. Urticarial venulitis. Dermatologic Therapy 2000; 13:400-408.

31. Cherrez Ojeda I, Lopez G, Uraga E. Revista nuestros hospitales 2002;23: 34-35.

32. Wiesnieski J. Urticarial vasculitis. Current Opinion in Reumatology 2000; 12 :24-31.

33. Donnell BF, Barr RM, Blac AK, Francis DM, Greaves MW. Intravenous immunoglobulin in chronic autoimmune urticaria. Br J Dermatol 1998; 138:101-6.

34. Confino-Cohen R, Aharoni D, Goldberg A, Gurevitch I, Buchs A, Weiss M, Weissgarten J, Rapoport MJ. Evidence for aberrant regulation of the p21Ras pathway in PBMCs of patients with chronic idiopathic urticaria. J Allergy Clin Immunol. 2002 Feb; 109(2):349-56.

35. Watson NT, Weiss EL, Harter PM. Famotidine in the treatment of acute urticaria. Clin Exp Dermatol. 2000; 25(3):186-9. 

36. Simons FE, Sussman GL, Simons KJ. Effect of the H2-antagonist cimetidine on the pharmacokinetics and pharmacodynamics of the H1-antagonists hydroxyzine and cetirizine in patients with chronic urticaria. J Allergy Clin Immunol. 1995; 95(3):685-93.

37. Sansom JE, Brooks J, Burton JL, Archer CB. Effects of H1- and H2-antihistamines on platelet-activating factor and bradykinin-induced inflammatory responses in human skin. Clin Exp Dermatol 1996; 21(1):33-7.

38. Sharpe GR, Shuster S. In dermographic urticaria H2 receptor antagonists have a small but therapeutically irrelevant additional effect compared with H1 antagonists alone. Br J Dermatol. 1993; 129(5):575-9.

39. Bleehen SS, Thomas SE, Greaves MW, Newton J, Kennedy CT, Hindley F, Marks R, Hazell M, Rowell NR, Fairiss GM, et al. Cimetidine and chlorpheniramine in the treatment of chronic idiopathic urticaria: a multi-centre randomized double-blind study. Br J Dermatol. 1987;117(1):81-8.

40. Leznoff A, Josee RG. Association of chronic urticaria and angioedema with thyroid autoimmunity. Arch Dermatol 1983;119:636-40.

41. Leznoff A, Sussman GL. Síndrome of idiopathic chronic urticaria and angioedema with thyroid autoimmunity: study of 90 patients. J Allergy Clin Immunol 1989;84:66-71

42. Zauli D, Deleonardi G, Foderaro S. Thyroid autoimmunity in chronic urticaria. Allergy Asthma Proc 2001;22(2):93-95

43. Menachem Rottem. Chronic urticaria and autoimmune thyroid disease: Is there a link? Autoimunity Reviews 2003;2:69-72

44. Cazar T, Cherrez Ojeda I, Uraga E. Revista nuestros hospitales 2005 in press

45. Kozel M, Mekkes J, Bossuyt P. Natural course of physical and chronic urticaria and angioedema in 220 patients. J Am Acad Dermatol 2001;45:387-91

46. Grattan CEH, Francis DM, Hide M. Detection of circulating histaminereleasing autoantibodies with functional properties of anti IgE in chronic urticaria. Clin Exp Allergy 1991;21: 695-704.

47. Juhlin L. Alternative treatments for severely affected patients with urticaria. Journal of Investigative Dermatology Simposium Proceedings 2001;6:157-159.

48. Zuberbier T, Greaves M. Management of urticaria: A consensus report Journal of Investigative Dermatology Simposium Proceedings 2001;6:128-131.

49. Cherrez Ojeda I, Uraga E. Urticaria cronica y enfermedad tiroidea. CILAD 2003. Comunicación libre 

Para descargar el PDF del artículo
Diagnóstico de urticaria crónica en Guayaquil

Haga click aquí